Relationship between the final dose of febuxostat and changes in MDA‐LDL level, LDL‐C level, and MDA‐LDL/LDL‐C
In the febuxostat group, 62, 52, and 75 patients had drug dosages of 10, ≤20 to <40 (20 mg, Association between time and the estimated changes in the (A) MDA‐LDL level, (B) LDL‐C level, and (C) MDA‐LDL/LDL‐C ratio according to the dose of febuxostat. LDL‐C, low‐density lipoprotein cholesterol; MDA‐LDL, malondialdehyde‐modified low‐density lipoprotein.